The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Subscribe To Our Newsletter & Stay Updated
